Wilson C B
Department of Neurological Surgery, University of California, School of Medicine, San Francisco.
Neurosurg Clin N Am. 1990 Jan;1(1):139-59.
Growth characteristics and size, irrespective of endocrine activity, predict the nonendocrine clinical presentation of a pituitary adenoma. Anatomic classification by degree of sellar destruction (grade) and extrasellar extension (stage) has value in determining prognosis and in designing therapy, and magnetic resonance imaging provides optimal diagnostic information. The transsphenoidal approach is the preferred surgical technique for most pituitary adenomas and the treatment of choice for those secreting growth hormone (acromegaly) or adrenocorticotropic hormone (Cushing's disease, Nelson's syndrome) and certain nonsecreting tumors. Opinions differ on the initial treatment for prolactin-secreting adenomas; whether most patients should be treated medically or surgically and whether bromocriptine or irradiation should be reserved for surgical failures are still being debated. From experience in a series of 1813 pituitary adenomas, the author surveys tumors of the pituitary region and the role surgery plays in their management.
垂体腺瘤的生长特征和大小,无论其内分泌活性如何,均可预测其非内分泌临床表现。根据蝶鞍破坏程度(分级)和鞍外扩展情况(分期)进行的解剖学分类,对于确定预后和设计治疗方案具有重要价值,而磁共振成像可提供最佳诊断信息。经蝶窦入路是大多数垂体腺瘤的首选手术技术,也是分泌生长激素(肢端肥大症)或促肾上腺皮质激素(库欣病、尼尔森综合征)的垂体腺瘤以及某些无分泌功能肿瘤的首选治疗方法。对于分泌催乳素的垂体腺瘤的初始治疗,目前存在不同观点;大多数患者应接受药物治疗还是手术治疗,以及溴隐亭或放射治疗是否应留作手术失败后的治疗手段,仍在争论之中。根据对1813例垂体腺瘤的研究经验,作者对垂体区域的肿瘤以及手术在其治疗中的作用进行了综述。